Search Results

There are 13471 results for: content related to: Prescribing patterns of antiparkinsonian agents in Europe

  1. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  2. Antipsychotic Prescribing Patterns and the Treatment of Extrapyramidal Symptoms in Older People

    Journal of the American Geriatrics Society

    Volume 43, Issue 9, September 1995, Pages: 967–973, Susan C. Kalish, Rhonda L. Bohn, Helen Mogun, Robert J. Glynn, Jerry H. Gurwitz and Jerry Avorn

    Article first published online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1995.tb05559.x

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Article first published online : 12 JUN 2015, DOI: 10.1002/mds.26295

  4. Usefulness of Antiparkinsonian Drugs during Neuroleptic Treatment and the Effect of Clonazepam on Akathisia and Parkinsonism Occurred after Antiparkinsonian Drug Withdrawal: A Double-Blind Study

    Psychiatry and Clinical Neurosciences

    Volume 46, Issue 3, September 1992, Pages: 733–739, Jun Horiguchi and Ohichi Nishimatsu

    Article first published online : 17 MAR 2008, DOI: 10.1111/j.1440-1819.1992.tb00549.x

  5. Antiparkinsonian agents and long-term neuroleptic treatment

    Acta Psychiatrica Scandinavica

    Volume 55, Issue 4, April 1977, Pages: 251–260, J. Gerlach, P. T. Rasmussen, L. Hansen and P. Kristjansen

    Article first published online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1977.tb00170.x

  6. Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro

    Journal of Neuroscience Research

    Volume 91, Issue 10, October 2013, Pages: 1371–1381, Kenjiro Ono, Jun-ichi Takasaki, Ryoichi Takahashi, Tokuhei Ikeda and Masahito Yamada

    Article first published online : 1 AUG 2013, DOI: 10.1002/jnr.23256

  7. Antiparkinsonian Effects of Novel Adenosine A2A Receptor Antagonists

    Archiv der Pharmazie

    Volume 344, Issue 1, January 2011, Pages: 20–27, Anna Drabczyńska, Małgorzata Zygmunt, Jacek Sapa, Barbara Filipek, Christa E. Müller and Katarzyna Kieć-Kononowicz

    Article first published online : 18 NOV 2010, DOI: 10.1002/ardp.201000124

  8. You have free access to this content
    Initiation of medications for Parkinson's disease: a qualitative description

    Journal of Clinical Nursing

    Volume 25, Issue 1-2, January 2016, Pages: 127–133, Ju Young Shin and Barbara Habermann

    Article first published online : 30 SEP 2015, DOI: 10.1111/jocn.13009

  9. Limitations of current Parkinson's disease therapy

    Annals of Neurology

    Volume 53, Issue S3, 2003, Pages: S3–S15, Olivier Rascol, Pierre Payoux, Fabienne Ory, Joaquim J. Ferreira, Christine Brefel-Courbon and Jean-Louis Montastruc

    Article first published online : 24 MAR 2003, DOI: 10.1002/ana.10513


    Acta Psychiatrica Scandinavica

    Volume 51, Issue 2, February 1975, Pages: 110–118, I. C. A. Martin

    Article first published online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1975.tb00220.x

  11. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  12. Some New Piperazino Derivatives as Antiparkinson and Anticonvulsant Agents

    Archiv der Pharmazie

    Volume 316, Issue 8, 1983, Pages: 690–694, Jagdish C. Agarwal, Chandishwar Nath, Manju Sharma, Gyan P. Gupta, Krishna P. Bhargava and Kripa Shanker

    Article first published online : 23 SEP 2006, DOI: 10.1002/ardp.19833160808

  13. Interindividual variation of serum haloperidol concentrations in Japanese patients – clinical considerations on steady-state serum level–dose ratios

    Journal of Clinical Pharmacy and Therapeutics

    Volume 28, Issue 2, April 2003, Pages: 97–101, E. Yukawa, R. Ichimaru, T. Maki, K. Matsunaga, M. Anai, M. Yukawa, S. Higuchi and Y. Goto

    Article first published online : 23 APR 2003, DOI: 10.1046/j.1365-2710.2003.00460.x

  14. Clozapine use pattern in persons with and without treatment for Parkinson's disease in real-world conditions: a naturalistic study in a community-based sample

    Acta Psychiatrica Scandinavica

    Volume 130, Issue 6, December 2014, Pages: 487–497, H. Verdoux and E. Pambrun

    Article first published online : 9 OCT 2014, DOI: 10.1111/acps.12344

  15. Poster session 2: Parkinson's Disease

    Movement Disorders

    Volume 17, Issue S5, November 2002, Pages: S65–S114,

    Article first published online : 21 OCT 2002, DOI: 10.1002/mds.10350

  16. Perphenazine for schizophrenia

    Intervention Review

    The Cochrane Library

    Benno Hartung, Stephanie Sampson and Stefan Leucht

    Published Online : 6 MAR 2015, DOI: 10.1002/14651858.CD003443.pub3

  17. Adenosine 2A Receptor Antagonists for the Treatment of Motor Symptoms in Parkinson's Disease

    Movement Disorders Clinical Practice

    Volume 2, Issue 4, December 2015, Pages: 331–340, Emmanuelle Pourcher and Philippe Huot

    Article first published online : 25 JUL 2015, DOI: 10.1002/mdc3.12187

  18. Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users

    Acta Neurologica Scandinavica

    Volume 105, Issue 1, January 2002, Pages: 8–12, D. A. M. C. Van De Vijver, R. A. C. Roos, P. A. F. Jansen, A. J. Porsius and A. De Boer

    Article first published online : 22 JAN 2002, DOI: 10.1034/j.1600-0404.2002.00132.x

  19. Poster session 2, Abstracts 345–694

    Movement Disorders

    Volume 19, Issue S9, 2004, Pages: S129–S244,

    Article first published online : 10 MAY 2004, DOI: 10.1002/mds.20176

  20. Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP-lesioned marmosets: Mediation by D2, not D3, dopamine receptors

    Movement Disorders

    Volume 21, Issue 12, December 2006, Pages: 2090–2095, Michael P. Hill, Paula Ravenscroft, Steven G. McGuire, Jonathan M. Brotchie, Alan R. Crossman, Catherine Rochat and Mark J. Millan

    Article first published online : 21 SEP 2006, DOI: 10.1002/mds.21106